Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$43.83 USD
-0.42 (-0.95%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $43.84 +0.01 (0.02%) 4:42 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PRAX 43.83 -0.42(-0.95%)
Will PRAX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for PRAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRAX
Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates
Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates
PRAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
Praxis Precision Medicines (PRAX) Upgraded to Buy: Here's Why
Biotech Stock Roundup: PRAX, VKTX Up on Study Results & MRNA, REGN Give Updates
Other News for PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Health Care Stocks Whale Activity In Today's Session
Praxis Precision Medicines (NASDAQ:PRAX): A Wild Rollercoaster Ride
Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Corbus Pharmaceuticals (CRBP)
Praxis Precision Medicines to Participate in Upcoming Investor Conferences